7 recruiting, 2 not yet recruiting, 1 enrolling by invitation, 1 unknown. 11 Phase 2, 4 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Recruiting 7, Not yet recruiting 2, Enrolling by invitation 1, Unknown 1 |
| Phase 1 | 4 | Recruiting 3, Not yet recruiting 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Crohn Disease (CD): new trials by email Literature Review of Crohn Disease (CD) trials Research Report on Crohn Disease (CD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HB-adMSCs for the Treatment of Crohn's Disease HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem Cells, 0.9% sodium chloride - Crohn Disease (CD) | Phase 2 | Recruiting | Hope Biosciences Research Foundation | 46 | 2026-07-14 | 2026-08-06 |
| DB-3Q for the Treatment of Medically Refractory Crohn's Disease DB-3Q, Placebo - Crohn Disease (CD) | Phase 2 | Recruiting | Direct Biologics, LLC | 36 | 2026-06-01 | 2026-09-01 |
| Clostridium Butyricum in Stenosing Crohn's Disease Clostridum Butyricum Capsule, Trehalose - Crohn Disease (CD) | Phase 1 / Phase 2 | Recruiting | San Giovanni Addolorata Hospital | 40 | 2026-05-08 | 2026-09-04 |
| Modafinil For Fatigue in IBD: A Feasibility Randomised Controlled Trial Modafinil, Placebo - Crohn Disease (CD), Ulcerative Colitis (UC) | Phase 2 | Not yet recruiting | Imperial College London | 70 | 2026-02-01 | 2025-12-22 |
| Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease 25mg adalimumab-680LT and 15/25 mg risankizumab-800CW, Adalimumab-680LT 25mg, Risankizumab-800CW 15 mg/25 mg - Ulcerative Colitis (UC), Crohn Disease (CD) | Phase 1 / Phase 2 | Not yet recruiting | University Medical Center Groningen | 30 | 2026-01-15 | 2026-01-14 |
| Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of Refractory Ano-perineal Fistulas in Crohn's Disease injection of thawed SVF - Crohn Disease (CD) | Phase 1 / Phase 2 | Recruiting | Assistance Publique Hopitaux De Marseille | 25 | 2025-12-30 | 2026-06-05 |
| Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease Tirzepatide, Standard of care treatment - Crohn Disease (CD) | Phase 2 | Recruiting | Washington University School of Medicine | 60 | 2025-05-13 | 2026-06-05 |
| Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease After surgery for Crohn's disease, eligible patients will be randomized 1:1 to receive oral EXL01 or placebo with or without SoC treatment (based on investigator decision) for up to 24 weeks - Crohn Disease (CD) | Phase 2 | Recruiting | Madeleine Bezault | 80 | 2025-03-31 | 2026-11-18 |
| Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease Risankizumab-800CW 4.5 mg, Risankizumab-800CW 15 mg, Risankizumab-800CW 25 mg - Ulcerative Colitis (UC), Crohn Disease (CD) | Phase 1 / Phase 2 | Recruiting | University Medical Center Groningen | 18 | 2024-11-08 | 2025-03-05 |
| Evaluation of the Efficacy of Local Budesonide Treatment in Children with Crohn's Disease Located in the Esophagus And/or Stomach And/or Duodenum budesonide, omeprazole (proton pump inhibitor) - Crohn Disease (CD) | Phase 2 / Phase 3 | Enrolling by invitation | Medical University of Warsaw | 114 | 2024-07-30 | 2024-12-06 |
| FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients 68Ga-FAPi-46 - IBD (Inflammatory Bowel Disease), Crohn Disease (CD) | Phase 2 | Unknown | Dalia Lartey | 20 | 2023-08-31 | 2024-09-19 |
Crohn Disease (11) · Colitis, Ulcerative (4) · Inflammatory Bowel Diseases (4) · Fatigue (1)
Digestive System Diseases (11) · Gastroenteritis (11) · Gastrointestinal Diseases (11) · Intestinal Diseases (11) · Inflammatory Bowel Diseases (7) · Colitis (4) · Colonic Diseases (4) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Budesonide (1) · Modafinil (1) · Omeprazole (1) · Postoperative Period (1) · Proton Pump Inhibitors (1) · Sodium Chloride (1) · Tirzepatide (1) · Trehalose (1)
University Medical Center Groningen (2) · Assistance Publique Hopitaux De Marseille (1) · Dalia Lartey (1) · Direct Biologics, LLC (1) · Hope Biosciences Research Foundation (1) · Imperial College London (1) · Madeleine Bezault (1) · Medical University of Warsaw (1) · San Giovanni Addolorata Hospital (1) · Washington University School of Medicine (1)
Netherlands (3) · United States (3) · France (2) · Italy (1) · Poland (1) · United Kingdom (1)
Andres Yarur, MD (1) · Calum Moulton (1) · Louis Cohen, MD (1) · Mark Lowenberg, MD PhD (1) · Matthieu Allez (1) · Parakkal Deepak, MBBS, MS (1) · Thanh Cheng, MD (1)
2025 (1)